Prevention or treatment of sleep disorders using dexmedetomidine formulation

JP2025092508APending Publication Date: 2025-06-19BIOXCEL THERAPEUTICS INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2025030902
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-10-15
Filing Date
2025-02-28
Publication Date
2025-06-19

Smart Images

  • Figure 2025092508000001_ABST
    Figure 2025092508000001_ABST
Patent Text Reader

Abstract

To provide a composition suitable for oral transmucosal administration (sublingual) comprising dexmedetomidine.SOLUTION: A composition is useful for the treatment of sleep disorders such as insomnia and capable of providing sleep on demand. The composition comprises an effective amount of dexmedetomidine or pharmaceutically acceptable salts thereof, solvates thereof, or derivatives thereof, formulated for delivery of dexmedetomidine across a subject's oral mucosa.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Macrocyclic polymorphs, compositions containing such polymorphs, and methods of use and manufacture thereof.

    JP2010516681A

  • Pharmaceutical formulations and compositions of phenylephrine for transmucosal absorption

    JP2011506337A

  • Dexmedetomidine sublingual composition and method of use

    JP2012526854A

  • Inhalation delivery methods and devices

    US20100196286A1